|
|||||
|
|
COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production,but none is linked to disease severity |
|
| Authors: | Wei Jiang Douglas Johnson Ruth Adekunle Hughes Heather Wanli Xu Xiaomei Cong Xueling Wu Hongkuan Fan Lars-Magnus Andersson Josefina Robertson Magnus Gisslén |
| Affiliation: | 1. Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA;2. Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA;3. Department of Medicine, Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina, USA Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA;4. University of Connecticut School of Nursing, Storrs, Connecticut, USA;5. Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA;6. Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA;7. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden |
| Abstract: | |
| Keywords: | autoantibodies autoantibodies against type I interferons COVID-19 SARS-CoV-2 |